Jardiance
/
Jardiance (empagliflozin) is a medication belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, used to improve glycemic control in adults with type 2 diabetes mellitus. It is taken as an oral tablet and is available by prescription only. Patients are advised that Jardiance may increase the risk of urinary tract infections and should not be used in patients with severe renal impairment or end-stage renal disease.
FAQs about Jardiance
What should I do if I miss a dose?
If you miss a dose of Jardiance, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Jardiance while pregnant or breastfeeding?
The use of Jardiance during pregnancy is not recommended, as there are no adequate and well-controlled studies in pregnant women. It is important to discuss with your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding. This guidance is outlined in the Warnings and Precautions section of the label.
Can I stop taking Jardiance suddenly?
There is no specific warning against abrupt discontinuation of Jardiance mentioned in the label. However, it is advisable to consult your healthcare provider before making any changes to your medication regimen. This information is derived from the general guidance provided in the label.
How should I store Jardiance?
Jardiance should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is specified in the Storage section of the label.
Similar Drugs
25
commonly-prescribed
medication.